Room for more funding analysis for Malaria Consortium SMC [2017]
 Share
The version of the browser you are using is no longer supported. Please upgrade to a supported browser.Dismiss

 
View only
 
 
ABCDEFGHIJKLMNOPQRSTUVWXYZ
1
2
This sheet was completed by GiveWell based on internal records on donations and conversations with Malaria Consortium
3
4
5
6
7
Scope of analysisNotes
8
9
Unit of analysis (full organization or program of a larger organization)Malaria Consortium SMCE.g., "SCI unrestricted," "Malaria Consortium SMC," or "Sightsavers GiveWell-specific deworming projects"
10
Analysis 'as of' dateAugust 1, 2017Roughly. GiveWell and Malaria Consortium discussed available funding for SMC in August 2017
11
End date of the analysis: GiveWell's next allocation decisionNovember 30, 2018
12
Date by which funds need to be received (or committed) for them to impact plans prior to GiveWell's next funding allocationJanuary 31, 2018This is based on past discussions with Malaria Consortium about the timing of SMC (roughly June/July to September/October) and the lead time needed to order drugs and plan programs
13
14
15
16
Funds on handAmountNotes
17
21
Uncommitted, unreserved funds (estimated for the end of 2017)$257,929ACCESS-SMC ends in August 2017. Our understanding is that the only other funds Malaria Consortium has for SMC are those directed by GiveWell.
22
23
24
25
Projected revenueValue from same period in previous yearAre there any reasons why last year's revenue is not a reasonable projection for next year (ignoring variation in GiveWell-influenced funding)?Projection (before GiveWell's 2017 recommendation)Notes
26
29
Projected revenue from donors who are not influenced by GiveWell's research, between August 1, 2017 and January 31, 2018--$0Malaria Consortium told us that there are some other funders that it is speaking to about the possibility of supporting SMC. Malaria Consortium does not believe these conversations will lead to significant funding, relative to the spending opportunities, in 2018.
30
Funding held by GiveWell as of August 1, 2017 for supporting Malaria Consortium SMC--$31,261Incorporated in the above estimate of uncommitted, unreserved funds
31
Projected revenue from donors who give based on GiveWell's top charity list, but do not follow our recommendation for marginal funding, between August 1, 2017 and January 31, 2018$45,015Malaria Consortium's SMC program was added as a recommended charity in November 2016, but most donations are made in December so adjusting this only a small amount$50,000GiveWell maintains both a list of all top charities that meet our criteria and a recommendation for which charity or charities to give to to maximize the impact of additional donations, given cost-effectiveness of remaining funding gaps.
32
[For programs that are part of a larger org] Funding expected for the program from parent organization's unrestricted funding000Malaria Consortium told us that it does not have unrestricted funding available for significant allocations to programs.
33
34
35
36
Bottom line
37
38
'Baseline' funding pot for Malaria Consortium SMC to allocate by January 31, 2018$339,190
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100
101
102
103
104
105
Loading...
Main menu